A groundbreaking new cancer drug developed by a Chinese company is making waves in the global biotech industry. In late-stage trials, Ivonescimab outperformed Keytruda, the world's top-selling cancer medication.
Copyright © 2020 CGTN. Beijing ICP prepared NO.16065310-3